This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer CenterSarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center Sound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology.